Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07600203 · ClinicalTrials.gov registry record · NA
A Double-blind, Placebo-controlled Evaluation of the Effect of the Erchonia® EVRL on Chronic Jaw Pain Arising From TMJ
A NA study, sponsored by Erchonia Corporation.
- Recruiting
- Registry status
- NA
- Development phase
- 64
- Enrollment target
NCT07600203 is a NA study that is actively recruiting participants, run by Erchonia Corporation. The registered enrollment target is 64 participants.
The verdict
NCT07600203, a NA study, is actively recruiting participants, sponsored by Erchonia Corporation.
- RECRUITING
- Registry status
- NA
- Development phase
- 64 participants
- Enrollment target
Study Summary
The purpose of this clinical study is to determine the effectiveness of the Erchonia EVRL, manufactured by Erchonia Corporation (the Company), in providing temporary relief of nociceptive musculoskeletal chronic jaw pain arising from temporomandibular joint (TMJ).
Interventions
- DEVICE Placebo Device
- DEVICE Erchonia® EVRL™
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 64 participants |
| Start Date | 2026-05-14 |
| Est. Completion | 2027-12-22 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07600203
The ClinicalTrials.gov registry entry for NCT07600203 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 64 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Erchonia Corporation, which has 34 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo Device is the first listed.
NCT07600203 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07600203 about?
NCT07600203 is a clinical study titled "A Double-blind, Placebo-controlled Evaluation of the Effect of the Erchonia® EVRL on Chronic Jaw Pain Arising From TMJ". The purpose of this clinical study is to determine the effectiveness of the Erchonia EVRL, manufactured by Erchonia Corporation (the Company), in providing temporary relief of nociceptive musculoskeletal chronic jaw pain arising from temporomandibular joint (TMJ).
What is the current status of trial NCT07600203?
This trial is currently recruiting. It is a NA study. The enrollment target is 64 participants. The study started on 2026-05-14. Estimated completion is 2027-12-22.
What interventions are being tested in trial NCT07600203?
The interventions under investigation include: Placebo Device (DEVICE), Erchonia® EVRL™ (DEVICE).
Who is sponsoring clinical trial NCT07600203?
This trial is sponsored by Erchonia Corporation, which has 34 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.